According to John Zhang, founder and CEO of the New Hope Fertility Center, universal PGS will likely increase success rates of IVF further.
A study by researchers in Italy found that preimplantation genetic diagnosis and screening combined led to more successful pregnancies per transfer but fewer women had embryos transferred.
The genetic diagnostics firm has developed an NGS-based test that combines PGS, PGD, and informativity testing, and presented initial results at a recent conference.
The team built on a previous approach that used single-cell sequencing to screen for chromosomal abnormalities in embryos from couples undergoing IVF.
The firm plans to incorporate mtDNA analysis into its preimplantation genetic screening services this month.
The method could have future applications in preimplantation genetic diagnosis and circulating tumor cell analysis.
RHS recently acquired an Arrayjet Marathon instrument to produce EmbryoCellect, which competes with PGS kits sold by Illumina, Agilent Technologies, OGT, and others.
The company's goal is to transition from a one-test provider to a full-service genetic testing company in the reproductive health and potentially other markets.
The FAST-SeqS test screens embryos for chromosomal aneuploidies prior to implantation in an in vitro fertilization setting.
NEW YORK (GenomeWeb) – Illumina has launched its VeriSeq test for preimplantation genetic screening on the MiSeq platform, the company said this week.
The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.
Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.
Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.
In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.